Upgrade to Pro
— share decks privately, control downloads, hide ads and more …
Speaker Deck
Features
Speaker Deck
PRO
Sign in
Sign up for free
Search
Search
PharmaX White paper
Search
PharmaX
September 12, 2022
Technology
14k
0
Share
Embed
Copy iframe code
Copy JS code
Copy link
Start on current slide
PharmaX White paper
PharmaX
September 12, 2022
More Decks by PharmaX
See All by PharmaX
YOJO Brand Book
pharma_x
0
3.5k
PharmaX Company Deck for Engineers
pharma_x
2
2.2k
PharmaX Company Deck
pharma_x
1
43k
Other Decks in Technology
See All in Technology
名刺メーカーDevグループ 紹介資料
sansan33
PRO
0
1.2k
SO-101×VLAによる3色キューブのピック&プレース
abeja
0
180
【CEDEC2026】『Relink』を拡張せよ - 『GRANBLUE FANTASY: Relink - Endless Ragnarok』の開発速度と品質を守るCI運用
cygames
PRO
0
150
【CEDEC2026】『ウマ娘 プリティーダービー』 英語版のキャラクターの方言や口調をローカライズするための創造的アプローチ
cygames
PRO
1
240
DatadogのBits Chatが開発組織にもたらしたもの / What Bits Chat Has Brought Us
sms_tech
1
190
サイバー捜査員研修(前半)
nomizone
1
2k
Service Connect 上のサービスに ECS Service の外側から到達できなかった話
ota1022
1
220
攻撃と防御で学ぶAI時代のプロダクトセキュリティ演習
recruitengineers
PRO
9
2.5k
AWS ネットワーク構築でハマった(ハマりかけた) 5選とそこから得た教訓
nagisa53
4
200
研究開発部の紹介 / Sansan R&D Profile
sansan33
PRO
4
24k
ホームラボ紹介
y_sera15
0
150
Forza Horizon 6 のテレメトリ機能で 自動運転に使えそうな学習データを集める話
henjin0
0
160
Featured
See All Featured
Breaking role norms: Why Content Design is so much more than writing copy - Taylor Woolridge
uxyall
0
360
The State of eCommerce SEO: How to Win in Today's Products SERPs - #SEOweek
aleyda
2
11k
SERP Conf. Vienna - Web Accessibility: Optimizing for Inclusivity and SEO
sarafernandez
2
1.5k
Building Flexible Design Systems
yeseniaperezcruz
330
40k
Pawsitive SEO: Lessons from My Dog (and Many Mistakes) on Thriving as a Consultant in the Age of AI
davidcarrasco
0
210
Discover your Explorer Soul
emna__ayadi
2
1.2k
Exploring the Power of Turbo Streams & Action Cable | RailsConf2023
kevinliebholz
37
6.5k
Measuring Dark Social's Impact On Conversion and Attribution
stephenakadiri
2
250
Ruling the World: When Life Gets Gamed
codingconduct
0
290
Embracing the Ebb and Flow
colly
88
5.1k
Effective software design: The role of men in debugging patriarchy in IT @ Voxxed Days AMS
baasie
0
470
Skip the Path - Find Your Career Trail
mkilby
1
180
Transcript
͔͔Γ͚ͭༀہΛ࣮ݱ͢Δ ༀہDXͱϦϞʔτༀࡎࢣ σʔλ͔Βඥղ͘ɺϦϞʔτༀࡎࢣͷظͱల
ʢCʣPharmaX Inc. 2022 All Rights Reserve 2 ࣍ ۀքಈ ༀہDXͷ࣮ଶͱ՝
ϦϞʔτༀࡎࢣͷՄೳੑ PharmaXͷऔΈ ͍͞͝ʹ P.03-05 P.06-12 P.13-15 P.16-22 P.23-25
ʢCʣPharmaX Inc. 2022 All Rights Reserve 3 ۀքಈ ༀہΛऔΓר͘େ͖ͳมԽ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 4 ۀքಈɹༀہΛऔΓר͘େ͖ͳมԽ ۙɺༀہΛऔΓר͘େ͖ͳมԽ͕ى͖͍ͯΔ มԽͷϙΠϯτʮༀہͷσδλϧ׆༻ʯͱʮༀࡎࢣͷಇ͖ํվֵʯ
ΦϯϥΠϯༀࢦಋͷ߃ٱԽϦϞʔτༀࡎࢣͷղېɺిࢠॲํͤΜಋೖɺௐࡎͷ֎෦ҕୗʹؔ͢Δݕ౼ ͳͲɺༀہΛऔΓר͘େ͖ͳมԽ͕͜ͷͰى͖͍ͯΔɻ ΦϯϥΠϯༀࢦಋ ిࢠॲํͤΜʢ20231݄ࢪߦ༧ఆʣ ௐࡎͷ֎෦ҕୗʢݕ౼தʣ ΦϯϥΠϯྍ ిΦϯϥΠϯͰͷༀͷઆ໌͕Մೳʹ ▶ױऀ͞·ༀہʹग़͔ͣɺࣗʹ͍ͳ͕ΒༀΛड͚औΔ͜ͱ͕Ͱ͖Δ ిΦϯϥΠϯͰͷྍ͕Մೳʹ ▶ױऀ͞·පӃʹग़͔ͣɺࣗʹ͍ͳ͕ΒྍΛड͚Δ͜ͱ͕Ͱ͖Δ ϦϞʔτༀࡎࢣʢ2022ࢪߦ༧ఆʣ ༀࡎࢣͷࡏۈ͕Մೳʹ ▶ༀࡎࢣ͕ༀࢦಋΛߦ͏ॴͷཧత੍͕ղআ͞ΕΔ ࢴͷॲํͤΜͷిࢠԽ͕Մೳʹ ▶ࢴͷॲํͤΜͷཧతΓͱΓ͕ͳ͘ͳΔ ϦϑΟϧॲํͤΜʢ20224݄ࢪߦʣ 1ຕͷॲํͤΜͰɺͳ্͘ݶͰ͘Γ͔͓͑͠ༀͷॲํ͕Մೳʹ ▶ॲํͤΜΛΒ͏ͨΊ͚ͩͷ͕ݮΔ ͜Ε·Ͱༀہ͝ͱʹߦ͍ͬͯͨରۀͷཧతू͕Մೳʹ ▶ରۀͷޮԽʹΑΓɺରਓॆͯΔ͕࣌ؒ૿͑Δ 1 2 3 4 5 6
ʢCʣPharmaX Inc. 2022 All Rights Reserve 5 ۀքಈɹༀہΛऔΓר͘େ͖ͳมԽ ҩྍͷ࣭ҩྍΞΫηε্ͷͨΊʮ͔͔Γ͚ͭༀہʯͷస͕ٸ ɾॲํͤΜड࣌Ҏ֎ͷରਓۀॆ࣮
ɾௐࡎޙͷϑΥϩʔΞοϓଟࡎ༻ͷରԠ ɾηϧϑϝσΟέʔγϣϯͷࢧԉͷ݈߁αϙʔτ ʮ͔͔Γ͚ͭༀہʯͷ࣮ݱʹDX͕ඞਢ ͜Ε͔Βͷ࣌ ʮͲͷҩྍػؔΛडͯ͠ɺༀہ͔͔Γ͚ͭʯ ௐࡎޙͷϑΥϩʔΞοϓଟࡎ༻ͷରԠ͚ͩͰͳ͘ɺηϧϑέΞɾηϧϑϝσΟέʔγϣϯࢧԉͷ݈ ߁αϙʔτۀͷॆ࣮ٻΊΒΕ͍ͯΔɻ ظ͞ΕΔରਓۀͷ͞ΒͳΔॆ࣮ Ҭแׅ έΞ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 6 ༀہDXͷ࣮ଶͱ՝ ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX
ʢCʣPharmaX Inc. 2022 All Rights Reserve 7 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ͔͔Γ͚ͭػೳ࣮ݱʹରਓۀͷॆ࣮ʹ͚ͨରۀͷޮԽ͕ඞཁ ͜Ε·Ͱͷༀࡎࢣͷۀͷத৺ରۀͰ͕͋ͬͨɺςΫϊϩδʔΛ׆༻ͨ͠ରۀͷޮԽΛߦ
͍ɺༀࡎࢣͷରਓۀΛॆ࣮͍ͤͯ͘͜͞ͱ͕ٻΊΒΕ͍ͯΔɻ ޮԽ ମݧͷ্ DX ɾॲํ༰ͷνΣοΫ ɾஸೡͳༀࢦಋ ɾΞϑλʔϑΥϩʔ ɾ݈߁αϙʔτ ɾҩࢣͷٙٛরձͷ࿈ܞ ରਓۀ ରۀ ɾॲํͤΜཧ ɾૹۀ ɾࡏݿཧ ɾใुࢉఆ ɾༀࡎަ ɾௐࡎ ɾༀࡎࠪ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 8 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ରۀͷDXࣄྫ ௐࡎϓϩηεʹϩϘοτΛ׆༻͢Δ͜ͱͰରۀΛޮԽ͢Δༀہొɻ·ͨɺௐࡎͷ֎෦ҕୗʹͭ
͍ͯ҆શੑ୲อͷॴࡏͳͲͷͱڞʹ͕ٞ։࢝͞Ε͍ͯΔɻ ϩϘοτௐࡎ ॲํσʔλΛೖྗ͢Δ͜ͱͰɺༀͷϐοΩϯά͔Βṝྔɺׂɺ แ·ͰΛϩϘοτ͕ߦ͏͜ͱɻۀͷޮԽͱ͍͏ҙຯ߹͍͚ͩ Ͱͳ͘ɺਓҝతͳϛεΛ͙ͱ͍͏ׂظ͞Ε͍ͯΔɻ ը૾Πϝʔδ ௐࡎͷ֎෦ҕୗ ※ݕ౼த ॲํͤΜΛड͚औͬͨༀہ͕ɺผͷༀہʹௐࡎۀΛҕୗ͢Δ͜ͱɻ தখༀہͳͲ͕ҕୗʹΑͬͯରਓۀΛΑΓڧԽ͍͚ͯ͠Δͱظ ͞ΕΔɻ2022ΑΓް࿑লʹͯݕ౼͕։࢝͞Ε͕ͨɺ҆શੑͷ୲อ ͷॴࡏͳͲͷ͕ଟ͘ɺ৻ॏʹٞ͞Ε͍ͯΔɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 9 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ରਓۀΛࢧԉ͢ΔDXࣄྫ ରਓۀͷॆ࣮ͷͨΊʹɺױऀ͞·ͷঢ়گѲΛԁʹͨ͠ΓɺༀہͰͷใ࿈ܞΛࢧԉͨ͠Γ͢ΔIT
πʔϧ͕ొɻ༷ʑͳػೳΛूͤͯ͞ༀࡎࢣͷۀޮԽΛࢧԉ͢Δπʔϧଟ͍ɻ ిࢠༀྺπʔϧ ΦϯϥΠϯༀࢦಋπʔϧ ϏσΦ௨ػೳʹΑΓΦϯϥΠϯͰױऀ͞·ͱༀࢦಋ͕Ͱ͖Δͩ ͚Ͱͳ͘ɺॲํͤΜͷΦϯϥΠϯडΩϟογϡϨεܾࡁɺళฮ ཧͳͲ༷ʑͳपลػೳࡌɻΦϯϥΠϯྍͱڞʹఏڙ͢Δا ۀଟ͘ɺΫϦχοΫͱͷ࿈ܞՄೳʹɻ ༀہͷϨηίϯͱ࿈ಈ͠ɺױऀ͞·ͷॲํྺ෭࡞༻ྺɺༀࢦಋ ༰ͳͲΛهɾཧ͢ΔγεςϜɻΫϥυܕͰར༻͘͢͠ ͳͬͨΓɺༀࢦಋΛ͠ͳ͕ΒༀྺΛهͰ͖ͨΓɺༀࡎࢣͷۀ ޮΛߴΊΔπʔϧ͕ొ͍ͯ͠Δɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 10 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX ”ༀہDX”ਐΉͷͷɺ͔͔Γ͚ͭༀہͷ࣮ݱʹ՝͕ Q.ҎԼͷ࣮ࢪසΛڭ͍͑ͯͩ͘͞
Q.ༀہʹDXπʔϧΛಋೖ͍ͯ͠·͔͢ʁ ग़యɿPharmaXʮༀہۀʹؔ͢Δௐࠪʯ20228݄ ɾΦϯϥΠϯༀࢦಋ πʔϧ༁ ɾిࢠϨηίϯ ɾిࢠༀྺ ɾίϛϡχέʔγϣ ϯɹɹπʔϧ ༀہDXπʔϧಋೖ ͔͔Γ͚ͭͷ࣮ଶ ͍ 95% ৗతͳίϛϡχέʔγϣϯ ݈߁αϙʔτ(පؾͷ༧ͳͲ) ༀࢦಋͷ࣌ؒ 80%ͷༀہͰ 5ະຬ 70%ͷༀہͰ Θ͔ͣͳױऀ͞·ͷΈ࣮ࢪ 75%ͷༀہͰ Θ͔ͣͳױऀ͞·ͷΈ࣮ࢪ ΦϯϥΠϯༀࢦಋ 75%ͷༀہͰ 5%ҎԼͷ࣮ࢪ ͍͍͑ 5% ΄ͱΜͲͷༀہͰITπʔϧͷ׆༻͕ਐΜͰ͍ΔͷͷɺༀࢦಋΞϑλʔϑΥϩʔɺࠒͷ݈߁αϙʔτ ͳͲɺ͔͔Γ͚ͭػೳʹ՝ҙࣝΛ࣋ͭༀہ͕ଟ͍ɻ ɹ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 11 ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX πʔϧΛಋೖ͢Δ͚ͩͰৗʹ͓͚Δ·Ͱख͕ճΒͳ͍࣮ଶ ITπʔϧΛಋೖͨ͠ͷͷɺैདྷͷۀʹՃ͑ͯৗతͳίϛϡχέʔγϣϯ݈߁αϙʔτ·Ͱख͕ճΒ
ͳ͍ɻༀࡎࢣ͕গͳ͍ༀہͰͦͷ͕ݦஶͳҰํɺ૿һ͢Δ͜ͱݱ࣮తͰͳ͍ɻ ग़యɿPharmaXʮༀہۀʹؔ͢Δௐࠪʯ20228݄ ैདྷܕͷༀہͰༀࡎࢣΛ૿һ͢Δ͜ͱʹ ݱ࣮తͳ͕͋͠͞Δ Q.ϑΥϩʔΞοϓͷͨΊͷ ૿һݕ౼Λ͍ͯ͠·͔͢ʁ ૿һ༧ఆ͕͋Δ 15% ૿һ༧ఆ͕ͳ͍/ ͍͕ͨ͠Ͱ͖ͳ͍ 85% Q.ళฮ͋ͨΓͷ ༀࡎࢣ ༀࡎࢣ͕গͳ͍ༀہ΄Ͳױऀ͞·ͷ ʮ͔͔Γ͚ͭʯΛेʹ࣮ࢪͰ͖ͯͳ͍՝ҙࣝ Q.ༀ͔Β࣍ճདྷہ·Ͱ ίϛϡχέʔγϣϯΛ ױऀ͞·ͱͱΕ͍ͯ·͔͢ʁ Q.ױऀ͞·ͷ ݈߁αϙʔτ ࣮ࢪͰ͖͍ͯ·͔͢ʁ 4໊ҎԼ 70% 5ਓҎ্ʹൺ4ਓະຬͷ߹ͷ࣮ࢪׂ߹ 1/2 38% ױऀ͞·Ҏ্ʹͱΕ͍ͯΔ ױऀ͞·Ҏ্ʹͰ͖͍ͯΔ 20% 14% 30% 5໊Ҏ্ 4໊ҎԼ 5໊Ҏ্ 4໊ҎԼ ༀࡎࢣ ༀࡎࢣ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 12 ͔͔Γ͚ͭػೳͷ࣮ݱʹॊೈͳༀࡎࢣਓࡐͷ׆༻͕ඞਢɻༀہ֎͔ΒΦϯϥΠϯༀࢦಋ͢ΔɺॴҦʮϦϞʔ τༀࡎࢣʯ͕ɺैདྷͷಇ͖ํͰۈͰ͖ͳ͘ͳͬͨજࡏༀࡎࢣͷ׆༻ΛՄೳʹ͢Δɻ ༀہDXͷ࣮ଶͱ՝ɹ͔͔Γ͚ͭༀہ࣮ݱͷΩʔDX
ༀࡎࢣਓࡐͷॊೈͳ׆༻͕͔͔Γ͚ͭػೳ࣮ݱͷՄೳੑΛߴΊΔ ҩༀɺҩྍػثͷ࣭ɺ༗ޮੑٴͼ ҆શੑͷ֬อʹؔ͢Δ๏ࢪߦنଇͷվਖ਼ જࡏༀࡎࢣ9ສਓ ͜Ε·Ͱɺࢪߦنଇୈ 15ͷ13ୈ߲̎ͷنఆʹج͖ͮɺༀࡎ ࢣ͕ΦϯϥΠϯༀࢦಋΛߦ͏߹ɺༀہ։ઃऀ֘ༀࡎ ࢣʹରͯ͠ɺༀࢦಋΛߦ͏ઃඋ͕͋Δༀہͷॴʹ͓͍ͯ ߦΘͤΔ͜ͱͱ͞Ε͍͕ͯͨɺ֘ༀہʹ͓͍ͯௐࡎʹैࣄ ͢Δༀࡎࢣͱ૬ޓʹ࿈བྷΛͱΔ͜ͱ͕Ͱ͖Δॴʹ͓͍ͯߦΘ ͤΔ͜ͱՄೳͱ͢Δɻ ʮϦϞʔτༀࡎࢣʯͷղې 2022 9݄ࢪߦ ༀࡎࢣࢿ֨Λ͍࣋ͬͯͳ͕Β৬ʹब͍͍ͯͳ͍ํ (ްੜ࿑ಇলྩୈඦࡾेࣣ߸ΑΓ)
ʢCʣPharmaX Inc. 2022 All Rights Reserve 13 ϦϞʔτༀࡎࢣͷՄೳੑ ϦϞʔτༀࡎࢣͷ׆༻͕ΩʔϙΠϯτ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 14 ϦϞʔτༀࡎࢣͷՄೳੑɹϦϞʔτༀࡎࢣͷ׆༻͕ΩʔϙΠϯτ ༀہ֎͔ΒԕִͰಇ͘ʮϦϞʔτༀࡎࢣʯͱ͍͏ಇ͖ํ ϦϞʔτༀࡎࢣͷಇ͖ํ
ϦϞʔτ ༀࡎࢣ ױऀ͞· ༀࢦಋͳͲ͕Մೳʹ ΦϯϥΠϯ௨πʔϧΛ༻͍ͯༀہ֎͔ΒԕִͰༀࡎࢣۀΛߦ͏ༀࡎࢣͷ͜ͱɻҭࣇհޢͷࣄ Ͱɺࢿ֨Λ࣋ͬͨ··ༀࡎࢣͱͯ͠ಇ͚͍ͯͳ͍ਓࡐͷ׆༻ΛՄೳʹ͢Δɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 15 ϦϞʔτༀࡎࢣͷՄೳੑɹϦϞʔτༀࡎࢣͷ׆༻͕ΩʔϙΠϯτ ϦϞʔτༀࡎࢣͱ͍͏ಇ͖ํͷظେ͖͍ ैདྷͷಇ͖ํͰༀہͰͷۈΛલఏͱ͍ͯͨͨ͠Ίɺ৷ग़࢈ɺҭࣇɺհޢͳͲͷࣄʹΑΓༀࡎ
ࢣͱͯ͠ಇ͘͜ͱΛఘΊΔέʔε͕ҰఆଘࡏɻϦϞʔτༀࡎࢣͰ͋ΕࡏͰͷಇ͖ํ͕࣮ݱՄೳɻ Q.ୀ৬࣌ͷཧ༝Λڭ͍͑ͯͩ͘͞ ͍ 62% Q.ൺֱతࣗ༝ʹ͕࣌ؒ͑ΔΑ͏ʹͳΕ ಇ͖ଓ͚ΒΕΔͱࢥ͍·͔͢ʁ ɾࢠͲͷૹΓܴ͑ͳͲɺ͔ࣗ͠Δਓ͕͍ͳ͍ͨΊ ɾ͜Ε·Ͱग़ۈ͕ଟ͘Ոͱͷ͕࣌ؒ࣋ͯͳ͔ͬͨ Q.ϦϞʔτϫʔΫͰಇ͍ͯΈ͍ͨͱࢥ͍·͔͢ ͍ 66% ɾ݈߁্ͷཧ༝͔Βಇ͘͜ͱ͕͘͠ͳͬͨ 13% ɾΩϟϦΞεςοϓ͕Ίͳ͔ͬͨ 13% ɾ৽͍͠ࣄʹνϟϨϯδͯ͠Έ͔ͨͬͨ 14% ༀہΛΊΔཧ༝ ϦϞʔτϫʔΫͷظ ৷ɾग़࢈ɾҭࣇɾհޢͱ ཱ྆Ͱ͖ͳ͘ͳͬͨ 40% ৬Ͱͷਓؒؔʹෆຬ͕ ͋ͬͨ 31% څ༩ʹෆຬ͕͋ͬͨ 29% ͍͍͑18% ͔Βͳ͍ 20% ͍͍͑34% ग़యɿPharmaXʮༀہༀࡎࢣͷ৬ܦݧʹؔ͢Δௐࠪʯʮༀہۀʹؔ͢Δௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 16 PharmaXͷऔΈ ϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 17 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ༀࡎࢣLINEͰ͍ͭͰ૬ஊͰ͖ΔOTCํͷECαʔϏεʮYOJOʯ ಠࣗͷΈͰ
ϦϞʔτༀࡎࢣΛ׆༻ 2019ΑΓༀࡎࢣLINEͰ͍ͭͰ૬ஊͰ͖ΔOTCํͷECαʔϏεʮYOJOʯΛఏڙɻར༻ऀͷ͔͔ Γ͚ͭ૬ஊΛ࣮ݱ͢ΔͨΊʹɺಠࣗͷΈΛ༻͍ͯϦϞʔτༀࡎࢣΛ׆༻ɻ ༀࡎࢣʹ૬ஊͰ͖Δ OTCํͷECαʔϏε ϦϞʔτༀࡎࢣ͕νϟοτԼॻ͖Λ࡞͠ɺళฮͷༀࡎࢣ͕ૹ৴͢ΔΈΛ ߏஙɻͷอ݈ॴ୲ऀΑΓ๏९क͍ͯ͠ΔࢫͷճΛ͍͍ͯΔɻಛڐ ٕज़ʢ*ಛڐ7029836ʣɻ ױऀ͞· ༀࡎࢣ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 18 Q.ϦϞʔτༀࡎࢣͱͯ͠ಇ͍ͯ Α͔ͬͨ͜ͱʁ PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ
20໊ͷༀࡎࢣ͕ϦϞʔτༀࡎࢣͱͯ͠׆༂͠ɺಇ͖͢͞Λ࣮ײ ҎલҰൠతͳༀہʹۈ͍ͯͨ͠ༀࡎࢣ͕ɺϦϞʔτༀࡎࢣʹͳΔ͜ͱͰॊೈͳಇ͖ํΛ࣮ݱɻ Ոఉͱࣄͷཱ͚྆ͩͰͳ͘ɺༀࡎࢣͱͯ͠ͷͷͨΊͷ࣌ؒࢿ͕Մೳʹɻ ॴͷ੍ݶ͕ͳ͍ ɾٸͳͷసۈ͕͋ͬͨͱͯ͠స৬Λߟ͑ͳͯ͘ࡁΜͩ ͕࣌ؒॊೈʹͳͬͨɺՈͱͷ࣌ؒ ͕૿͑ͨ ɾࢠͲͷٸͳମௐෆྑߦࣄɺश͍ࣄͳͲॊೈʹରԠͰ͖Δ ɾೖ͔ࣾͯ͠Β͜Ͳ͕ੜ·Εɺ࠺ͷαϙʔτ͜ͲͷΛɹ ɹݟΔ͕࣌ؒͱΕΔ ࣗݾݚᮎͷ͕࣌ؒ૿͑ͨ ɾ௨ۈ͕࣌ؒͳ͍ͨΊɺேबۀޙͷ࣌ؒΛ׆༻ͯ͠ษڧ͕ ɹͰ͖Δ ॴͷ੍ݶ͕ ͳ͘ͳͬͨ ۈ͕࣌ؒॊೈ ʹͰ͖ΔΑ͏ʹ ͳͬͨɾՈͱ ͷ͕࣌ؒ૿͑ͨ ࣗݾݚᮎͷͨΊ ͷ͕࣌ؒ૿͑ͨ ਓؒؔͷΈ ͕ͳ͘ͳΓಇ͖ ͘͢ͳͬͨ ͦͷଞ 50% 93% 93% 43% 7% ग़యɿPharmaXʮϦϞʔτༀࡎࢣͷಇ͖ํʹؔ͢Δௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 19 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ [ࢀߟ] ࣌ؒॴʹनΘΕͳ͍ϦϞʔτༀࡎࢣͱ͍͏ಇ͖ํ
ϦϞʔτۈʹΑͬͯ࣌ؒॴʹनΘΕͳ͍͜ͱͰɺༀہۈͰ͍͠ࣄͱՈఉͷཱ͕྆Մೳʹɻ ετϨεΛײͣ͡ɺࣗ༝ʹಇ͘͜ͱ͕Ͱ͖͍ͯΔɻ ࣌ؒॴʹनΘΕͣಇ͘͜ͱ͕ Ͱ͖ΔΑ͏ʹͳΓɺಇ͖͘͢ͳΓ·ͨ͠ɻ Ҏલͷ৬͔ࣗΒԕ͘ɺࢠͲͷૹΓܴ͑Λߟ͑Δͱޕޙ͔ Β͔͠ಇ͘͜ͱ͕Ͱ͖ͣༀࡎࢣͱͯ͠ࣄΛଓ͚Δͷ͕ݫ͍͠ͳ ͱײ͍ͯͨ͡ͱ͜ΖɺʮϦϞʔτༀࡎࢣʯͱ͍͏ଘࡏΛΓ·͠ ͨɻࠓͰ͏·ۭ͍ͨ࣌ؒ͘Λ͍ͳ͕Βɺಇ͘͜ͱ͕Ͱ͖͍ͯ ·͢ɻ 5:30 23:00 9:00 ۈ ४උ ୀۈ ͜ͲͨͪΛݟૹΔ ଉࢠͷ॓ΛݟΔɾՈࣄ εʔύʔۜߦ ່ͷؼΛग़ܴ͑ʙ 18:00 YOJOༀࡎࢣA͞Μͷ1 ௨ۈ͕ ෆཁʂ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 20 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ༀࡎࢣΩϟϦΞΛ֦ு͢Δબࢶͱͯ͠ͷʮϦϞʔτༀࡎࢣʯ Q.ϦϞʔτༀࡎࢣͱͯ͠
ༀࡎࢣࢿ֨Λ׆͔ͯ͠ಇ͖ଓ͚͍ͨͰ͔͢ʁ ϦϞʔτༀࡎࢣͱ͍͏ಇ͖ํༀࡎࢣਓࡐͷՁΛ͞Βʹ׆͔͢͜ͱʹܨ͕Δɻશࠃʹଘࡏ͢Δજࡏༀ ࡎࢣ׆༻ʹΑΓɺҩྍΞΫηεͷ্ͱҩྍͷ࣭ʹߩݙͰ͖ΔͷͰͳ͍͔ɻ ϦϞʔτͰ ಇ͖ଓ͚͍ͨ 86% ͲͪΒͰΑ͍ɺ Θ͔Βͳ͍ 14% ग़యɿPharmaXʮϦϞʔτༀࡎࢣͷಇ͖ํʹؔ͢Δௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 21 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ॊೈͳಇ͖ํༀࡎࢣ͕ױऀ͞·ͱ͖߹͍͍͢ڥ࣮ݱ ಇ͖͍͢ڥʹΑΓༀࡎࢣ͕৺ͷ༨༟Λ࣋ͬͯಇ͘͜ͱ͕Ͱ͖ɺױऀ͞·ʹΑΓ͖߹͍͘͢ͳΔɻ
ϦϞʔτͰױऀ͞·ͱରԠ͢Δ͜ͱ͕Ͱ͖Δ͜ͱͰɺױऀ͞·ରԠ ͢ΔༀࡎࢣࣗͷॅΈ׳ΕͨՈɺϦϥοΫεͰ͖ΔڥͰର͢Δ ͜ͱ͕Ͱ͖ΔͨΊ͓ޓ͍ʹ͍͢͠ͱࢥ͏ɻ ༀࡎࢣױऀ͞·ϦϥοΫε Ͱ͖ΔڥͰର͕Ͱ͖Δ ཧతڑ͋ͬͯྑ͍ؔΛ ங͘͜ͱ͕Ͱ͖Δͷ͕ັྗత ױऀ͞·ͱཧతڑ͋ͬͯɺױऀ͞·ͷΈʹدΓఴ͑ͨΓɺ ମௐͷมԽΛتΔؔੑͱͯັྗతͩͱࢥ͏ɻ ௨ৗͷༀہͰ༷ʑͳ੍ݶͰɺରԠͰ͖ͳ͍ױऀ͞·ͷΈঢ়ʹ ରԠͰ͖Δɻ·ͨॅΜͰ͍ΔॴʹؔΘΒͣɺױऀ͞·ͷ૬ஊʹରԠ ͢Δ͜ͱ͕Ͱ͖Δɻ ௨ৗͷༀہͰରԠͰ͖ͳ͍ ΈʹରԠͰ͖Δ ࡏͰಇ͚Δ͜ͱͰ༨༟Λͬ ͨಇ͖ํ͕Ͱ͖͍ͯΔ ϦϞʔτମ੍͕͍ࡏͰಇ͚Δ͜ͱͰɺ৬ͷมͳؾݣ͍ετ Ϩε͕ܰݮ͠ɺ༨༟Λ࣋ͬͨಇ͖ํ͕Ͱ͖͍ͯΔɻ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 22 PharmaXͷऔΈɹϦϞʔτༀࡎࢣͷ׆༻ʹΑΔ͔͔Γ͚ͭԽ ϦϞʔτༀࡎࢣͷ׆༻͕࣮ݱ͢Δ͔͔Γ͚ͭػೳ ॊೈͳༀࡎࢣͷ׆༻ʹΑΓɺৗͰͷܧଓతͳαϙʔτ͕ՄೳʹɻༀࡎࢣͷʹΑͬͯױऀ͞·ͷຬ
͕ߴ·Γɺ݈߁ҙࣝͷ্ʹد༩Ͱ͖ΔͷͰͳ͍͔ɻ ϦϞʔτༀࡎࢣͷ׆༻͔͔Γ͚ͭༀہ࣮ݱͷҰख 90ˋ ૬ஊ͢͠͞ʹຬ͍ͯ͠Δ YOJOͷױऀ͞· පӃͰ͋·ΓΛฉ͍ͯ͘Εͳ͔ͬͨΓɺ৺Ҽతͳͷ ͱͯ͠·ͱΊΒΕͯ͠·ͬͨΓͱɺෆ҆ࠓޙͲ͏͍ͯ͠ ͚͍͍ͷ͔Α͘Θ͔Βͳ͘ͳͬͯ͠·ͬͨͱ͖ɺༀࡎࢣ ͞Μ͕ʹͳͬͯߟ͑ͯͩͬͨ͘͞ʂ डͰ͋Ε࣌ؒΛݟܭΒ͏ ͜ͱ͕ඞཁ͚ͩΕͲɺLINEͰ ͋Εࣗͷ伱ؒ࣌ؒʹ࣭ ͤͯ͞Β͑Δ ૬ஊ͍ͨ͠ࣄΛϦΞϧλΠϜ Ͱ૬ஊग़དྷΔͷ͋Γ͕͍ͨ Ͱ͢ 80ˋ ݈߁ҙࣝΛ࣮ײ͍ͯ͠Δ YOJOͷױऀ͞· ͲͪΒͰͳ͍ 12% ຬ͍ͯ͠Δ 87% ෆຬͰ͋Δ 1% ҙࣝ͢ΔΑ͏ʹ ͳͬͨ 77% ͲͪΒͰͳ͍ 14% มΘΒͳ͍ 9% Q.૬ஊͷ͢͠͞ʹຬͰ͔͢ʁ Q.݈߁ҙࣝมԽ͠·͔ͨ͠ʁ ग़యɿPharmaXʮYOJOༀہʹର͢ΔϢʔβʔධՁͷௐࠪʯ20228݄
ʢCʣPharmaX Inc. 2022 All Rights Reserve 23 ͍͞͝ʹ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 24 ͍͞͝ʹ ϦϞʔτༀࡎࢣͷීٴʹ͚ͯ ղېʹͬͯϦϞʔτༀࡎࢣͷ׆༂ͱༀہͷ͔͔Γ͚ͭػೳͷॆ࣮͕ظ͞ΕΔɻҰํͰɺༀہۀʹ
ϦϞʔτༀࡎࢣΛ׆༻͢ΔϊϋΛ࣋ͭاۀݶఆతɻ PharmaXͰɺༀࡎࢣͷϦϞʔτϫʔΫʹΑͬͯױऀ͞·ͷஸ ೡͳ݈߁αϙʔτͱಇ͖͍͢ڥͷཱ྆Λ࣮ݱ ϦϞʔτϫʔΫʹΑΔશࠃ9ສਓͷજࡏༀࡎࢣͷ׆༂͕ༀࡎࢣ ͷ͔͔Γ͚ͭԽͷ伴 ɹɾϦϞʔτༀࡎࢣղېʹΑͬͯɺϦϞʔτༀࡎࢣͷ׆༂͕ظ͞ΕΔ ҰํͰɺༀہۀʹϦϞʔτༀࡎࢣΛ׆༻͢ΔϊϋΛ ࣋ͭاۀݶఆత 1 2 3
ʢCʣPharmaX Inc. 2022 All Rights Reserve 25 ͍͞͝ʹ ⁋ ༟հ
ॱఱಊେֶҩֶ෦ଔۀɻ ϔϧεέΞܥاۀʹͯࣄۀ։ൃΠϯλʔϯɻ ॱఱಊҩӃʹͯྟচͱݚڀʹैࣄͨ͠ޙɺ 201812݄ࣾઃཱ ͓͍߹Θͤઌ https://www.pharma-x.co.jp/ PharmaXגࣜձࣾɺױऀ͞·த৺ͷҩྍମݧΛ࣮ݱ͢ΔͨΊʹɺ ༀہྖҬʹ͓͚ΔDXΛਪਐ͍͖ͯ͠·͢ɻ ࣗࣾༀہΛத৺ʹɺϦϞʔτༀࡎࢣͱಠࣗΦϖϨʔγϣϯγεςϜΛߏங͠ɺ࣍ੈܕͷʮ͔͔Γ͚ͭΦϯϥΠϯༀ ہʯΛఏڙ͓ͯ͠Γ·͢ɻༀہྖҬʹ͓͚ΔDXࣄྫʹ͍ͭͯ͝հͰ͖Δ΄͔ɺॊೈʹύʔτφʔاۀ͞·ͱऔΓ ΈΛ͍͍͓ͤͯͨͩͯ͞Γ·͢ɻ औࡐґཔ͓Αͼ͓߹ͤ PharmaXגࣜձࣾɹ දऔకɾҩࢣ
ʢCʣPharmaX Inc. 2022 All Rights Reserve 26 ͍͞͝ʹ PharmaXௐࠪ֓ཁ ௐࠪςʔϚɿYOJOༀہʹର͢ΔϢʔβʔධՁͷௐࠪ
ௐࠪରɿYOJOༀہར༻ऀ ௐࠪํ๏ɿWebΞϯέʔτܗࣜͰ࣮ࢪ ༗ޮճɿ221݅ ௐ࣮ࠪࢪɿ2022/07/28ʙ2022/08/03 ௐࠪςʔϚɿༀہۀʹؔ͢Δௐࠪ ௐࠪରɿༀہༀࡎࢣͷ͏ͪʮܦӦऀɺϚωʔδϟʔɺ ཧༀࡎࢣɺҰൠࣾһʯ ௐࠪํ๏ɿΠϯλʔωοτϦαʔν ༗ޮճɿ1000݅ ௐ࣮ࠪࢪɿ2022/08/08ʙ8/12 ௐࠪςʔϚɿϦϞʔτༀࡎࢣͷಇ͖ํʹؔ͢Δௐࠪ ௐࠪରɿYOJOༀہैۀһ ௐࠪํ๏ɿWebΞϯέʔτܗࣜͰ࣮ࢪ ༗ޮճɿ14݅ ௐ࣮ࠪࢪɿ2022/07/28ʙ2022/08/03 ௐࠪςʔϚɿༀہༀࡎࢣͷ৬ܦݧʹؔ͢Δௐࠪ ௐࠪରɿༀہༀࡎࢣ ௐࠪํ๏ɿΠϯλʔωοτϦαʔν ༗ޮճɿ1061݅ ௐ࣮ࠪࢪɿ2022/08/08ʙ8/10